IPO registrations (S-1, F-1) · Registrants
INVO Fertility, Inc.
- SEC CIK
- 1417926 · filings on EDGAR ↗
- Former names
- NAYA Biosciences, Inc. (2024–2025); INVO Bioscience, Inc. (2009–2024); EMY'S SALSA AJI DISTRIBUTION COMPANY, INC. (2007–2009)
- Registration
- Form S-1, first filed 2009-12-21, last 2026-07-24; 11 initial registrations, 14 amendments
- Outcome
- Final prospectus filed 2020-11-13; declared effective 2009-12-30; withdrawal requested 2024-10-22
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus 3841
- Incorporated in
- NV
- Business address
- 5582 BROADCAST COURT, Sarasota, FL 34240
- EIN
- 20-4036208
- Ticker
- IVF (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- INVO Fertility, Inc. on the corporate pages
Offering terms
- Final price
- $8.00 per share (424B4 filed 2020-11-13)
- Shares sold
- 3,625,000
- Gross proceeds
- $29,000,000 before underwriting discounts and any over-allotment option
- Listing
- OTCQB under the symbol INVO
- Lead underwriters
- Roth Capital Partners (2,138,750 shares)
- Syndicate
- Colliers Securities LLC (543,750); Paulson Investment Company, LLC (942,500)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: INVO BIOSCIENCE, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Form 5500 plan sponsor: INVO BIOSCIENCE, INC. EXACT (EIN (EXACT))
- Form D issuer: INVO Bioscience, Inc. EXACT (CIK (EXACT))
- SEC filer: INVO Bioscience, Inc. EXACT (CIK (EXACT))
Filings 43
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2009-12-21 | S-1 | S-1 (registration) | INVO Bioscience, Inc. | 0001185185-09-001326 ↗ |
| 2009-12-29 | S-1/A | S-1/A (amendment) | INVO Bioscience, Inc. | 0001185185-09-001366 ↗ |
| 2009-12-30 | EFFECT | EFFECT (declared effective) | INVO Bioscience, Inc. | 9999999995-09-003649 ↗ |
| 2010-08-02 | EFFECT | EFFECT (declared effective) | INVO Bioscience, Inc. | 9999999995-10-002321 ↗ |
| 2018-12-20 | S-1 | S-1 (registration) | INVO Bioscience, Inc. | 0001185185-18-002217 ↗ |
| 2019-07-29 | S-1/A | S-1/A (amendment) | INVO Bioscience, Inc. | 0001185185-19-001027 ↗ |
| 2019-09-09 | S-1/A | S-1/A (amendment) | INVO Bioscience, Inc. | 0001185185-19-001240 ↗ |
| 2019-09-16 | EFFECT | EFFECT (declared effective) | INVO Bioscience, Inc. | 9999999995-19-002099 ↗ |
| 2020-07-08 | S-1 | S-1 (registration) | INVO Bioscience, Inc. | 0001185185-20-000969 ↗ |
| 2020-07-15 | EFFECT | EFFECT (declared effective) | INVO Bioscience, Inc. | 9999999995-20-001817 ↗ |
| 2020-09-21 | S-1 | S-1 (registration) | INVO Bioscience, Inc. | 0001185185-20-001342 ↗ |
| 2020-09-29 | S-1/A | S-1/A (amendment) | INVO Bioscience, Inc. | 0001185185-20-001363 ↗ |
| 2020-09-30 | S-1/A | S-1/A (amendment) | INVO Bioscience, Inc. | 0001185185-20-001373 ↗ |
| 2020-10-20 | S-1/A | S-1/A (amendment) | INVO Bioscience, Inc. | 0001185185-20-001449 ↗ |
| 2020-10-20 | S-1/A | S-1/A (amendment) | INVO Bioscience, Inc. | 0001185185-20-001451 ↗ |
| 2020-11-09 | S-1/A | S-1/A (amendment) | INVO Bioscience, Inc. | 0001185185-20-001521 ↗ |
| 2020-11-12 | EFFECT | EFFECT (declared effective) | INVO Bioscience, Inc. | 9999999995-20-003147 ↗ |
| 2020-11-13 | 424B4 | 424B4 (final prospectus) | INVO Bioscience, Inc. | 0001185185-20-001587 ↗ |
| 2021-04-16 | EFFECT | EFFECT (declared effective) | INVO Bioscience, Inc. | 9999999995-21-001472 ↗ |
| 2023-06-23 | S-1 | S-1 (registration) | INVO Bioscience, Inc. | 0001493152-23-022239 ↗ |
| 2023-07-03 | S-1/A | S-1/A (amendment) | INVO Bioscience, Inc. | 0001493152-23-023263 ↗ |
| 2023-07-07 | S-1 | S-1 (registration) | INVO Bioscience, Inc. | 0001493152-23-024000 ↗ |
| 2023-07-07 | EFFECT | EFFECT (declared effective) | INVO Bioscience, Inc. | 9999999995-23-002030 ↗ |
| 2023-07-24 | S-1/A | S-1/A (amendment) | INVO Bioscience, Inc. | 0001493152-23-025309 ↗ |
| 2023-07-31 | S-1/A | S-1/A (amendment) | INVO Bioscience, Inc. | 0001493152-23-025968 ↗ |
| 2023-08-02 | S-1/A | S-1/A (amendment) | INVO Bioscience, Inc. | 0001493152-23-026400 ↗ |
| 2023-08-03 | EFFECT | EFFECT (declared effective) | INVO Bioscience, Inc. | 9999999995-23-002272 ↗ |
| 2023-08-07 | 424B4 | 424B4 (final prospectus) | INVO Bioscience, Inc. | 0001493152-23-027029 ↗ |
| 2024-10-22 | RW | RW (withdrawal request) | NAYA Biosciences, Inc. | 0001493152-24-041913 ↗ |
| 2024-12-17 | S-1 | S-1 (registration) | NAYA Biosciences, Inc. | 0001493152-24-050393 ↗ |
| 2024-12-20 | EFFECT | EFFECT (declared effective) | NAYA Biosciences, Inc. | 9999999995-24-003857 ↗ |
| 2025-01-07 | S-1/A | S-1/A (amendment) | NAYA Biosciences, Inc. | 0001493152-25-001123 ↗ |
| 2025-01-08 | S-1/A | S-1/A (amendment) | NAYA Biosciences, Inc. | 0001493152-25-001437 ↗ |
| 2025-01-13 | EFFECT | EFFECT (declared effective) | NAYA Biosciences, Inc. | 9999999995-25-000092 ↗ |
| 2025-01-14 | 424B4 | 424B4 (final prospectus) | NAYA Biosciences, Inc. | 0001493152-25-002078 ↗ |
| 2025-10-14 | S-1 | S-1 (registration) | INVO Fertility, Inc. | 0001493152-25-018032 ↗ |
| 2025-12-17 | S-1 | S-1 (registration) | INVO Fertility, Inc. | 0001493152-25-028163 ↗ |
| 2025-12-29 | EFFECT | EFFECT (declared effective) | INVO Fertility, Inc. | 9999999995-25-003941 ↗ |
| 2025-12-31 | 424B4 | 424B4 (final prospectus) | INVO Fertility, Inc. | 0001493152-25-029789 ↗ |
| 2026-02-02 | S-1 | S-1 (registration) | INVO Fertility, Inc. | 0001493152-26-004766 ↗ |
| 2026-02-10 | EFFECT | EFFECT (declared effective) | INVO Fertility, Inc. | 9999999995-26-000518 ↗ |
| 2026-07-24 | S-1 | S-1 (registration) | INVO Fertility, Inc. | 0001493152-26-034621 ↗ |
| 2026-08-04 | EFFECT | EFFECT (declared effective) | INVO Fertility, Inc. | 9999999995-26-002538 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2020-11-09 | S-1/A | registration statement | $8.00 | 2,035,000 | $16,280,000 | OTCQB INVO | 1 | primary document; price line, shares headline, proceeds computed | document ↗ | |
| 2020-11-13 | 424B4 | final prospectus | $8.00 | 3,625,000 | $29,000,000 | OTCQB INVO | 3 | primary document; price line, shares headline, proceeds computed, underwriting table 3 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Bowdring Robert Joseph Jr | Director; Director,Officer; Officer | Chief Financial Officer; Treasurer & Secretary | 10 | 2017–2019 | |
| Karloff Kathleen t | Director; Director,Officer; Director,Officer,TenPercentOwner | CEO; CEO / Chairman; CEO/Chairman; CEO & President; Chairwoman and CEO | 14 | 2017–2020 | |
| Ranoux Claude | Director,Officer,TenPercentOwner; TenPercentOwner | President | 40 | 2017–2019 | |
| Shum Steve | Director; Director,Officer | Chief Executive Officer | 12 | 2017–2025 | |
| Campbell Michael Jos. | Director; Director,Officer | Chief Operating Officer; COO & VP Business Development | 10 | 2018–2023 | |
| Doody Kevin | Director,Officer | Medical Director | 5 | 2019–2022 | |
| HOOPES DEBRA ROBBINS | Officer | Acting CFO and PFO | 1 | 2019 | |
| DAVIS TRENT D | Director | 7 | 2019–2025 | ||
| Szot Matthew K | Director | 8 | 2020–2025 | ||
| Ryan Barbara | Director | 7 | 2020–2025 | ||
| Segal Jeffrey | Director | 5 | 2020–2022 | ||
| Messina Rebecca | Director | 6 | 2021–2025 | ||
| AWM Investment Company, Inc. | TenPercentOwner | 4 | 2021 | ||
| Goren Andrea | Officer | Chief Financial Officer | 6 | 2021–2025 | |
| Krigsvold Terah Renee | Officer | Chief Financial Officer | 1 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2023-04-06 | INVO Bioscience, Inc. | Other Health Care | $2,976,200 | $2,976,200 | 1 | 1 |
| 2023-02-17 | INVO Bioscience, Inc. | Other Health Care | $500,000 | $500,000 | 2 | 2 |
| 2023-01-11 | INVO Bioscience, Inc. | Other Health Care | $3,500,000 | $275,000 | 7 | 1 |
| 2020-05-28 | INVO Bioscience, Inc. | Other Health Care | $3,500,000 | $3,494,840 | 22 | 2 |
| 2018-01-24 | INVO Bioscience, Inc. | Other Health Care | $1,500,000 | $15,000 | 1 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Form D issuer | INVO Bioscience, Inc. | FL | Form D private offerings | CIK (EXACT) |
| SEC filer | INVO Fertility, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Business registration | INVO BIOSCIENCE, INC. | State business registries | EIN (EXACT, as the state registration reports it) | |
| Form 5500 plan sponsor | INVO BIOSCIENCE, INC. | EIN (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Surgical & Medical Instruments & Apparatus, FL first:
- XOMED SURGICAL PRODUCTS INC FL
- AMERICAN SCIENTIFIC RESOURCES INC FL
- IRADIMED CORP FL
- Vicor Technologies, Inc. FL
- MARIZYME, INC. FL
- VYCOR MEDICAL INC FL
- InspireMD, Inc. FL
- Sensus Healthcare, Inc. FL
- TREACE MEDICAL CONCEPTS, INC. FL
- BRAIN SCIENTIFIC INC. FL
In other datasets, the same topic (Technology) in FL:
- Form D issuer: 3D FUTURE VISION II, INC. (Form D private offerings)
- Lobbying client: 1-800-DONOTCALL (Federal lobbying (LDA))
Interests: Surgical & Medical Instruments & Apparatus · Technology